CD4 and acute myeloid leukemia: According to these data, a careful patient stratification based on CD4+ cell counts and karyotype may be suggested, considering induction chemotherapy a reasonable option mainly for HIV-associated AML with CD4+ cells > 200/μL and without unfavorable karyotype [32].